Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report-Reference-Cited by-同舟云学术

Late response to rosuvastatin and statin-related myalgia due to SLCO1B1, SLCO1B3, ABCB11, and CYP3A5 variants in a patient with Familial Hypercholesterolemia: a case report

Published:2021-01 Issue:1 Volume:9 Page:76-76
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann Transl Med

Author:

Dagli-Hernandez Carolina,de Freitas Renata Caroline Costa,Marçal Elisangela da Silva Rodrigues,Gonçalves Rodrigo Marques,Faludi Andre Arpad,Borges Jéssica Bassani,Bastos Gisele Medeiros,Los Bruna,Mori Augusto Akira,Bortolin Raul Hernandes,Ferreira Glaucio Monteiro,de Oliveira Victor Fernandes,Hirata Thiago Dominguez Crespo,Hirata Mario Hiroyuki,Hirata Rosario Dominguez Crespo

Publisher

AME Publishing Company

Subject

General Medicine

Link

https://atm.amegroups.com/article/download/59482/pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When the same treatment has different response: The role of pharmacogenomics in statin therapy;Biomedicine & Pharmacotherapy;2024-01

2. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

3. Pharmacogenomics in Cardiovascular Diseases;Pharmacogenomics in Clinical Practice;2023

4. Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia;Pharmaceutics;2022-04-27

5. Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease;Genes;2022-03-14